Hindering the Synchronization Between miR-486-5p and H19 lncRNA by Hesperetin Halts Breast Cancer Aggressiveness Through Tuning ICAM-1

Abstract

Background: Recently, a novel crosstalk between non-coding RNAs (ncRNAs) has been casted. However, this has been seldomly investigated in metastatic BC (mBC). H19 and miR-486-5p role in mBC is controversial. ICAM-1 is a recently recognized metastatic engine in mBC. Natural compounds were recently found to alter ncRNAs/target circuits. Yet, Hesperitin modulatory role in altering such circuits has never been investigated in mBC. Objective: The aim of this study is to investigate the impact of hesperitin on miR-486-5p/H19/ICAM-1 axis Methodology: BC patients (n=20) were recruited in the study. Bioinformatic analysis was performed using different prediction softwares. MDA-MB-231 and MCF-7 cells were cultured and transfected using several oligonucleotides or treated with serial dilutions of hesperitin. RNA was extracted and gene expression analysis was performed using q-RT-PCR. ICAM-1 protein levels were assessed using human ICAM-1 Elisa Kit. Cytotoxic potential of hesperitin against normal cells was assessed by LDH assay. Several functional analysis experiments were performed such as MTT, colony forming and migration assays. Results: The study showed that miR-486-5p and H19 has a paradoxical expression profiles in mBC patients. miR-486-5p mimics and H19 siRNAs repressed ICAM-1 and halted mBC hallmarks. A novel crosstalk between miR-486-5p and H19 was observed highlighting a bi-directional relationship between them. Hesperetin restored the expression of miR-486-5p, inhibited H19 lncRNA and ICAM-1 expression and selectively regressed mBC cell aggressiveness. Conclusion: miR-486-5p and H19 are inter-connected upstream regulators for ICAM-1 building up miR-486-5p/H19/ICAM-1 axis that has been successfully tuned in mBC cells by hesperitin

A Snapshot of Photoresponsive Liposomes in Cancer Chemotherapy and Immunotherapy: Opportunities and Challenges

“…Various immunological elements are found upon cellular examination of a typical TME, indicating an immune battle against the tumor. ,− The appearance of multiple cytokines, macrophages, neutrophils, and tumor-infiltrating lymphocytes (TILs), among others, signify an attempt of the host immune system to eradicate the tumor. ,− …”

Let-7a/cMyc/CCAT-1/miR-17-5p Circuit Modulates PDL-1 Expression and Atezolizumab Resistance in Triple Negative Breast Cancer

“…PBMCs were isolated from the whole blood by Ficoll-Hypaque centrifugation (Axis-Shield PoC AS, Norway) within 2 h of blood withdrawal following the manufacturer's protocol. The isolated PBMCs were cryopreserved and were stored at -80°c until further use [20,24].…”

MALAT-1: Immunomodulatory lncRNA hampering the innate and the adaptive immune arms in triple negative breast cancer

“…Deregulation of lncRNAs in several types of cancers emphasizes its association with tumor progression and carcinogenesis [25] . Accordingly, this rendered lncRNAs prognostic biomarkers in many cancers including BC [26] , [27] , [28] , [29] . Yet, the immunoncological side of several lncRNAs and their specific role at the tumor cell-immune cell synapse at the TME has been rarely investigated.…”